Gene Therapy Sponsor INTERACT, Pre-IND Meeting Confusion Lingers Despite FDA Guidance

 
• By Sue Sutter
  
Confusion
Despite the FDA's attempts to provide clarity, sponsors remain confused about the appropriate topics for INTERACT and pre-IND meetings. (Shutterstock)

More from Cell & Gene Therapies

More from Pathways & Standards